Company / SG&A per Share
IONIS PHARMACEUTICALS INC SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.49
FY2025
5-year range
$1.06 / $2.49
FY2021-FY2025
Trend
+34.6%
vs FY2024
Sector context
#72 of 210
Health Care
What the data says
At $2.49, IONIS PHARMACEUTICALS INC's sg&a per share ranks #139 of 210 in the Health Care sector. SG&A per Share has increased for 3 consecutive years, from $1.06 in FY2022 to $2.49 in FY2025.
Based on SEC 10-K filings.
2.49 in FY2025 with a 5-year CAGR of +7.4%.
Increased from $1.64 to $2.49 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +32.8%
- 5-Year CAGR
- +7.4%
- 10-Year CAGR
- -
Sector benchmark
#139 of 210 in Health CareTop 66% of 210This company $2.49 Sector average $29.50
▼
-91.5% below sector average
Key checks
Key Insights
- IONIS PHARMACEUTICALS INC's sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 34.6% year-over-year.
- Ranks #72 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.49 | +34.6% |
| FY2024 | $1.85 | +13.2% |
| FY2023 | $1.64 | +53.9% |
| FY2022 | $1.06 | -47.9% |
| FY2021 | $2.04 | +17.2% |
| FY2020 | $1.74 | +121.6% |
| FY2019 | $0.79 | +102.2% |
| FY2018 | $0.39 | -56.4% |
| FY2017 | $0.89 | +120.8% |
| FY2016 | $0.40 | +28.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026